Theodore Stamatakos, MD
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations.
Across 55 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$181
- Medtronic$68
- Pfizer$62
- Progenics Pharmaceuticals, Inc.$61
- Verity Pharmaceuticals Inc.$58
- Tolmar, Inc.$52
- plus $551 from 19 others
What the payments were for
- Food & beverage$99796%
- Education$374%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $181 |
| Medtronic(2 entities) | 4 | $68 |
| Pfizer | 4 | $62 |
| Progenics Pharmaceuticals, Inc. | 3 | $61 |
| Verity Pharmaceuticals Inc. | 3 | $58 |
| Tolmar, Inc. | 2 | $52 |
| Urovant Sciences Inc | 3 | $50 |
| Hollister Incorporated | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Agiliti Surgical, Inc. | 1 | $40 |
| Acerus Pharmaceuticals Corporation | 2 | $37 |
| Zyla Life Sciences, Inc. | 3 | $35 |
| Avadel Specialty Pharmaceuticals, LLC | 2 | $31 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| Boston Scientific | 2 | $29 |
| Endo Pharmaceuticals Inc. | 2 | $26 |
| Bayer | 1 | $25 |
| Dentsply IH Inc. | 2 | $24 |
| Aytu Biopharma, Inc. | 2 | $24 |
| Telix Pharmaceuticals | 1 | $22 |
| Convatec Inc. | 1 | $22 |
| Angiodynamics, Inc. | 1 | $20 |
| Olympus America Inc. | 1 | $17 |
| Procept Biorobotics Corporation | 1 | $16 |
| Coloplast | 1 | $15 |
How this compares
$1,034 in reported general payments places this provider in the 55th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 266 | $3,703 |
| Oxybutynin Chloride | 107 | $1,504 |
| Tolterodine Tartrate ErTolterodine Tartrate | 15 | $1,373 |
| Ciprofloxacin Hcl | 212 | $1,300 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 24 | $943 |
| Cephalexin | 74 | $712 |
| Finasteride | 74 | $709 |
| Testosterone Cypionate | 16 | $667 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 114 | $610 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $371 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $278 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 44 | $225 |
| Sildenafil Citrate | 14 | $70 |
| Diazepam | 14 | $10 |
Paid to pharmacies, not to this prescriber.
Other urology in Keene
- Martin GrossKeene$172K
- Arnold WillisKeene$15K
- George QuimbyKeene$49
- Arthur CrowleyKeene$43
- Mark FunkKeene$0
- Ramiro Madden-FuentesConcord$82K
- Jason AkermanManchester$53K
- Lori LernerLebanon$49K
- E William JohnsonExeter$27K
- John MunozManchester$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.